340B Pharmacy Program Compliance insight. ideas Kentucky Primary Care Association attention

Size: px
Start display at page:

Download "340B Pharmacy Program Compliance insight. ideas Kentucky Primary Care Association attention"

Transcription

1 340B Pharmacy Program Compliance Kentucky Primary Care Association Presented by: Scott Gold, CPA, Partner October 16, 2012 Brief Overview History of 340B Drug Program Discounted Pharmaceuticals Growing and High Profile Program Oversight Office of Pharmacy Affairs (OPA) Risks Hold Accountable What should you be doing? 1

2 History of 340B Pricing Program Originally created in 1992 Provides discounts on outpatient pharmacy drugs Program promotes access to affordable medications for certain safety-net providers, including FQHC s, FQHCLA s, other entities History of 340B Drug Pricing Program, continued Administered by the Office of Pharmacy Affairs (OPA) in the Health Resources Services Administration (HRSA) Participation in the 340B program can lead to significant cost savings and revenue generation 2

3 History of 340B Drug Pricing Program, continued Intent of program is to stretch scarce Federal resources as far as possible, ing more eligible patients and providing more comprehensive services Ultimate responsibility for compliance is at the covered entity level Discounted Pharmaceuticals Drug manufacturers provide upfront discounts to covered entities at either the ceiling price or potentially separately negotiated price which may be lower than ceiling price Ceiling price is based on the Average Manufacturer Price formula, less a discount (as low as $.01) 3

4 Discounted Pharmaceuticals Average savings estimated to be 25% to 50% Savings may be used for: Reduce price of pharmaceuticals for patients Expand services offered to patients Provide services to more patients Growing and High Profile Program With the Patient Protection and Affordable Care Act (PPACA), many changes to the 340B Program occurred, including: Can now contract with multiple pharmacies to provide 340b pricing to qualified patients Many new entities are now considered covered entities Strengthened the government s enforcement authority over both manufacturers and covered entities 4

5 Growing and High Profile Program These changes have significantly increased the level of 340B drugs purchased from manufacturers Government Accounting Office (GAO) conducted a study of the 340B program and in September 2011 report, GAO concluded HRSA was not doing enough to monitor the program Estimated $6 billion in 340B drug purchases Oversight Program Integrity HRSA Audits A-133 Compliance Supplement Certain CFDA s for June 30, 2012 audits Manufacturer audits Beginning 2013 Bureau Health Center Site Visits will Consider 340B 5

6 Risks Documentation Duplicate Discounts Diversion Risks - Documentation Policies and Procedures What you do How you do it Controls in place to ensure you did it Recertification Requirement Correct Data on OPA Database Match Scope of Project 6

7 Risks - Duplicate Discounts Equals Accessing the 340B Discount and Medicaid Rebate on same drug HRSA enrollment billing Medicaid or not Do you purchase and dispense 340B drugs for Medicaid or Medicaid Managed Care patients HRSA maintains Medicaid Exclusion file Risks - Diversion A drug is provided to an individual who are not a patient of that entity Entities should enroll all eligible outpatient or satellite sites Manage and track your inventory 7

8 Patient Definition Required to follow patient definition guidelines 61 Fed. Reg (October 24, 1996) Maintains records of the individuals health care Receives care by employee or contract employee of covered entity Services received are consistent with FQHC range of services Not a covered patient just because they fill their prescription at your pharmacy What Should You Be Doing Understand what you are currently doing Review Polices Review and update OPA registration Determine controls Perform controls 8

9 In-House Versus Contract In-House non-340b Inventory management Contract pharmacy: It is your Inventory! Controls Does your Organization fill scripts for referrals to doctors outside of your Organization? If not, should you? If so, how do you ensure compliance? 9

10 Medicaid & Medicaid Managed Care Know your State How does your State handle Medicaid Managed Care? Is Medicaid & Medicaid Managed Care eligible for 340B priced drugs? Understand the economics Recent Audits, Findings, and Communications Senator Grassley s letter to Duke Health System Contract pharmacy co-pays Contract pharmacy dispensation fees 10

11 Resources Office of Pharmacy Affairs (OPA) Phone: or Web: Pharmacy Services Support Center (PSSC) Phone: Web: pssc.aphanet.org Prime Vendor Program (PVP) - Apexus Phone: Web: E. St. Louis St. Springfield, MO Office: Fax: Scott W. Gold CPA Partner sgold@bkd.com Thank You! We welcome your comments & questions! 11

340B: WHAT ATTORNEYS NEED TO KNOW TODAY, TOMORROW AND IN THE FUTURE. March 3, 2016 ABA Emerging Issues in Healthcare Conference San Diego, CA

340B: WHAT ATTORNEYS NEED TO KNOW TODAY, TOMORROW AND IN THE FUTURE. March 3, 2016 ABA Emerging Issues in Healthcare Conference San Diego, CA 340B: WHAT ATTORNEYS NEED TO KNOW TODAY, TOMORROW AND IN THE FUTURE March 3, 2016 ABA Emerging Issues in Healthcare Conference San Diego, CA 2 Presentation Outline What you need to know Today 340B Program

More information

340B Pharmacy Program Best Practices

340B Pharmacy Program Best Practices 340B Pharmacy Program Best Practices December 8, 2015 Agenda 1. The Program and the Requirements 2. Program Compliance and Integrity (Best Practices) Internal Controls Policies and Procedures OPA Database

More information

America s Voice for Community Health Care

America s Voice for Community Health Care America s Voice for Community Health Care The National Association of Community Health Centers (NACHC) represents Community and Migrant Health Centers, as well as Health Care for the Homeless and Public

More information

Following this presentation, attendees should be able to: Identify key events in 340B landscape that occurred in 2015 and 2016.

Following this presentation, attendees should be able to: Identify key events in 340B landscape that occurred in 2015 and 2016. Following this presentation, attendees should be able to: Identify key events in 340B landscape that occurred in 2015 and 2016. Identify critical components of a compliance plan. List the different types

More information

COMPLIANCE IN THE 340B DRUG PRICING PROGRAM

COMPLIANCE IN THE 340B DRUG PRICING PROGRAM COMPLIANCE IN THE 340B DRUG PRICING PROGRAM Jason Atlas RPh MBA Manager, Education and Compliance Support Apexus Education and Compliance Support Team Apexus Education and Compliance Support Team 1 Objectives

More information

Steve Zielinski Regional Director SUNRx, LLC April 16, 2010

Steve Zielinski Regional Director SUNRx, LLC April 16, 2010 Steve Zielinski Regional Director SUNRx, LLC April 16, 2010 Mississippi Primary Care Association 340B Program Overview Contracted Pharmacy Model New Multiple Contract Pharmacy Elements Maintaining 340B

More information

What is the 340B Program?

What is the 340B Program? Emily Cook, Partner, McDermott Will & Emery Anne S. Daly, Senior Director of Compliance, Banner Health Karolyn Woo Miles, Principal, Deloitte & Touche LLP 1 What is the 340B Program? Federal drug discount

More information

This training will begin at 12:00pm ET. WebEx Technical Support: Or us at

This training will begin at 12:00pm ET. WebEx Technical Support: Or  us at This training will begin at 12:00pm ET WebEx Technical Support: 1-866-229-3239 Or e-mail us at nationalhivcenter@fenwayhealth.org Works with HIV/AIDS service organizations and community-based organizations

More information

6/11/2013. South Carolina Primary Health Care Association. Overview. 340B Essentials. Disclaimer. 340B Essentials. 340B Essentials

6/11/2013. South Carolina Primary Health Care Association. Overview. 340B Essentials. Disclaimer. 340B Essentials. 340B Essentials South Carolina Primary Health Care Association 2013 Clinical Network Retreat June 9, 2013 Preparing for and Surviving a 340B Audit presented by: Michael B. Glomb, Partner of Overview Key features of the

More information

340B Drug Pricing: Don t Become an HRSA Statistic. Wipfli LLP 1

340B Drug Pricing: Don t Become an HRSA Statistic. Wipfli LLP 1 340B Drug Pricing: Don t Become an HRSA Statistic October 13, 2017 Wipfli LLP 1 Today s Agenda 340B Drug Pricing Program Overview Program Benefit Eligibility Program in Operation Contract Pharmacy Regulatory

More information

Renee Gravalin, Partner

Renee Gravalin, Partner Experience the Eide Bailly Difference 340B Drug Program Renee Gravalin, Partner rgravalin@eidebailly.com 701.799.5449 Agenda Proposed Changes 1 Experience the Eide Bailly Difference Created in 1992 to

More information

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements

Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements WEDNESDAY, MARCH 19, 2014 1pm Eastern 12pm Central 11am

More information

1/16/2014. David Pointer President, SolutionsRx

1/16/2014. David Pointer President, SolutionsRx David Pointer President, SolutionsRx 417.679.2203 david@pointerlaw.com 1 340B Program Overview Physician-Administered Drugs Contract Pharmacies 340B Compliance Expanding 340B Utilization 2 Federally mandated

More information

340B Drug Pricing Program

340B Drug Pricing Program 340B Drug Pricing Program Mary Stepanyan, PharmD Candidate 2018 University of Southern California, School of Pharmacy Pro Pharma Pharmaceutical Consultants Under the preceptorship of Dr. Craig Stern WHY

More information

The 340B Drug Pricing Program: Opportunities for Community Pharmacists

The 340B Drug Pricing Program: Opportunities for Community Pharmacists The 340B Drug Pricing Program: Opportunities for Community Pharmacists by Marsha K. Millonig, MBA, RPh President,Catalyst Enterprises, LLC Goals: After completing this program, participants will be able

More information

The 340B Drug Pricing Program

The 340B Drug Pricing Program The 340B Drug Pricing Program Presentation at Alliance of Community Health Plans Medical Directors and Pharmacy Directors Meeting October 2012 Avalere Health LLC Avalere Health LLC The intersection of

More information

THE 340B DRUG DISCOUNT PROGRAM AND INTERPLAY WITH MEDICARE AND MEDICAID REIMBURSEMENT PRINCIPLES. Barbara Straub Williams.

THE 340B DRUG DISCOUNT PROGRAM AND INTERPLAY WITH MEDICARE AND MEDICAID REIMBURSEMENT PRINCIPLES. Barbara Straub Williams. THE 340B DRUG DISCOUNT PROGRAM AND INTERPLAY WITH MEDICARE AND MEDICAID REIMBURSEMENT PRINCIPLES I. History and Purpose of 340B Program Barbara Straub Williams March 2015 Section 340B of the Public Health

More information

Table of Contents. Executive Resources, LLC 2015, v. 2

Table of Contents. Executive Resources, LLC 2015, v. 2 2 Table of Contents I. Introduction II. Overview III. Contract Pharmacy and Arrangements IV. HRSA and 340B Data Base V. Software, Internal Control Systems and Management of Inventory VI. External Relationships

More information

10/2/2015. CPAs and ADVISORS 340B: COMPLIANCE MATTERS AND HERE S WHY MICHAEL R. EARLS, CPA DIRECTOR. experience access // 2 // experience access

10/2/2015. CPAs and ADVISORS 340B: COMPLIANCE MATTERS AND HERE S WHY MICHAEL R. EARLS, CPA DIRECTOR. experience access // 2 // experience access CPAs and ADVISORS experience access // 340B: COMPLIANCE MATTERS AND HERE S WHY MICHAEL R. EARLS, CPA DIRECTOR MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits HRSA & Manufacturer Audits

More information

Chapter 9 Medicaid and 340B

Chapter 9 Medicaid and 340B Chapter 9 Medicaid and 340B A. Introduction UPDATED 1. The complex intersection of Medicaid and 340B The intersection of 340B and Medicaid is one of the most complex and significant areas within any health

More information

340B Program New Developments and Increasing Scrutiny

340B Program New Developments and Increasing Scrutiny 340B Program New Developments and Increasing Scrutiny Todd Nova Hall Render tnova@hallrender.com Wisconsin Office of Rural Health Hospital Finance Workshop August 24, 2012 What We Will Cover 2 1 340B Program

More information

340B Drug Pricing Program: Participation, Eligibility and Program Integrity HOSPITALS June 26 th, 2014

340B Drug Pricing Program: Participation, Eligibility and Program Integrity HOSPITALS June 26 th, 2014 340B Drug Pricing Program: Participation, Eligibility and Program Integrity HOSPITALS June 26 th, 2014 LCDR Joshua E. Hardin MBA, RN/BSN, MLT U.S. Department of Health and Human Services Health Resources

More information

MATERIAL COVERED TODAY

MATERIAL COVERED TODAY MATERIAL COVERED TODAY This presentation has been designed to discuss compliance needs, proposed changes and best practices for covered entities in the 340B Drug Pricing Program This presentation should

More information

Contract Pharmacy Relationships

Contract Pharmacy Relationships Contract Pharmacy Relationships What is a contract pharmacy? 1 What is a contract pharmacy? Dispenses drugs to FQHC patients on behalf of FQHC Contract between FQHC and pharmacy Typically pharmacy not

More information

The Federal 340B Drug Discount Program. Compliance and Lessons Learned. Jason Reddish September 24, 2014

The Federal 340B Drug Discount Program. Compliance and Lessons Learned. Jason Reddish September 24, 2014 The Federal 340B Drug Discount Program Compliance and Lessons Learned Jason Reddish September 24, 2014 About Me Jason Reddish Attorney Powers Pyles Sutter & Verville PC 1501 M Street NW, 7 th Floor Washington,

More information

A Pharmacy s Guide to 340B Contract Pharmacy Services Best Practices

A Pharmacy s Guide to 340B Contract Pharmacy Services Best Practices A Pharmacy s Guide to 340B Contract Pharmacy Services Best Prepared by: Date: September 1, 2014 Table of Contents Overview... 1 Introduction to the 340B program... 3 340B Covered Entity Eligibility...

More information

340B Program Update & Recommendations for Monitoring Program Compliance October

340B Program Update & Recommendations for Monitoring Program Compliance October 340B Program Update & Recommendations for Monitoring Program Compliance October 2 2014 Speaker Biography Ray Albertina Director Deloitte & Touche LLP +1 (314) 342 4984 ralbertina@deloitte.com Ray is a

More information

Health Policy Explainer

Health Policy Explainer The 340B Drug Program Health Policy Explainer Created in 1992, the 340B Drug Discount Program is a little-known program that s getting an increasing amount of attention from hospitals, Congress and pharmaceutical

More information

340B Compliance, Audits & Opportunities

340B Compliance, Audits & Opportunities 340B Compliance, Audits & Opportunities NW Ohio HFMA February 15, 2018 David Layne, CPA Manager HRSA Audits Bizzell Group-Silver Spring, Maryland Prior Hospital experience Many are pharmacists Experienced

More information

11/5/2015 A&A PERSPECTIVE. HFMA Region 9 Conference November 15, Tracy Young, CPA, Partner Brian Bell, Director

11/5/2015 A&A PERSPECTIVE. HFMA Region 9 Conference November 15, Tracy Young, CPA, Partner Brian Bell, Director 340B MEGA GUIDANCE FROM AN A&A PERSPECTIVE HFMA Region 9 Conference November 15, 2015 Tracy Young, CPA, Partner Brian Bell, Director 1 MATERIAL COVERED TODAY The Health Resources and Services Administration

More information

8 th Annual Oncology Economics Summit Estimating the Impact of Recent Legislation on Future Growth in the 340B Program

8 th Annual Oncology Economics Summit Estimating the Impact of Recent Legislation on Future Growth in the 340B Program 8 th Annual Oncology Economics Summit Estimating the Impact of Recent Legislation on Future Growth in the 340B Program La Jolla, CA February 21-22, 2012 1 Legal Made Me Do It The opinions expressed in

More information

340B Drug Program Compliance: Focus on Disproportionate Hospitals

340B Drug Program Compliance: Focus on Disproportionate Hospitals 340B Drug Program Compliance: Focus on Disproportionate Hospitals Part II: 340B Drug Program Compliance: Pharmacy Operations and the DSH January 29, 2014 1 Faculty Stephen J. Weiser, JD, LLM Director 312-403-4284

More information

340B Program Risk: A Perspective for Pharmaceutical Manufacturers

340B Program Risk: A Perspective for Pharmaceutical Manufacturers CiiTA Monograph Series 340B Program Risk: A Perspective for Pharmaceutical Manufacturers EXECUTIVE SUMMARY The number of ineligible prescriptions purchased through the PHS 340B Drug Discount Program represents

More information

An Introduction to and Updated Regarding the 340B Federal Drug Discount Program

An Introduction to and Updated Regarding the 340B Federal Drug Discount Program An Introduction to and Updated Regarding the 340B Federal Drug Discount Program Chris Roberson, JD, MPH 317.871.0000 or 877.256.8837 Raphael Health Center Picture of CHC Describe how many centers and how

More information

FPNTC FAMILY PLANNING NATIONAL TRAINING CENTER

FPNTC FAMILY PLANNING NATIONAL TRAINING CENTER Demystifying 340B: Frequently Asked Questions Webinar February 13, 2018 FPNTC Responses to Unanswered Chat Questions Mindy McGrath, National Family Planning and Reproductive Health Association (NFPRHA)

More information

340B Program Contract Pharmacy Self-Audit Tool: Diversion

340B Program Contract Pharmacy Self-Audit Tool: Diversion Page 1 Purpose: The purpose of the Contract Pharmacy Self-Audit Tools is to improve contract pharmacies compliance with the 340B Program requirements. Covered entities remain responsible for the 340B drugs

More information

340B Guardian Model Overview

340B Guardian Model Overview 340B Guardian Model Overview Why monitor 340B program compliance? The 340B program has grown from less than $2B in total sales in 2002 to over $8B in sales in 2012. Currently, approximately 30,000 covered

More information

Statement of Conflicts of Interest

Statement of Conflicts of Interest Part 1 - Overview Debra A. Muscio, MBA, CHC, CCE, CFE SVP, Chief Audit, Ethics & Officer Community Medical Centers Karolyn Woo-Miles Senior Manager Deloitte & Touche LLP April 22, 2015 Statement of Conflicts

More information

Introduction. The Basics of the 340B Program. 340B Drug Discount Program Compliance, Audit & Enforcement Activity. Wesley R.

Introduction. The Basics of the 340B Program. 340B Drug Discount Program Compliance, Audit & Enforcement Activity. Wesley R. 340B Drug Discount Program Compliance, Audit & Enforcement Activity Wesley R. Butler Wes.Butler@BBB-Law.com Introduction Caveat This presentation is intended as an overview of a complex area of law and

More information

Pharmaceutical Summit on Business and Compliance Issues in Managed Markets

Pharmaceutical Summit on Business and Compliance Issues in Managed Markets Pharmaceutical Summit on Business and Compliance Issues in Managed Markets TRACK A: 340B PROGRAM CONSIDERATIONS A Panel Discussion By: Agenda Panel Introductions Overview of 340B Program Compliance Considerations

More information

340B MEGA GUIDANCE WHAT NOW? KENTUCKY HFMA WINTER INSTITUTE JANUARY 21, 2016

340B MEGA GUIDANCE WHAT NOW? KENTUCKY HFMA WINTER INSTITUTE JANUARY 21, 2016 340B MEGA GUIDANCE WHAT NOW? KENTUCKY HFMA WINTER INSTITUTE JANUARY 21, 2016 Brian Bell Director bbell@bkd.com Brenda Christman Managing Director bchristman@bkd.com MATERIAL COVERED TODAY The Health Resources

More information

340B MEGA GUIDANCE WHAT NOW? HFMA REGION 6 DECEMBER 16, 2015

340B MEGA GUIDANCE WHAT NOW? HFMA REGION 6 DECEMBER 16, 2015 340B MEGA GUIDANCE WHAT NOW? HFMA REGION 6 DECEMBER 16, 2015 Brian Bell Director bbell@bkd.com Claire Torrella Manager ctorrella@bkd.com MATERIAL COVERED TODAY The Health Resources and Services Administration

More information

2/25/2016. Today s Objectives. Disclaimer WHAT S NEW IN THE WORLD OF 340B?

2/25/2016. Today s Objectives. Disclaimer WHAT S NEW IN THE WORLD OF 340B? WHAT S NEW IN THE WORLD OF 340B? Jim Donnelly Vice President of Pharmacy Services Hudson Headwaters Health Network Jennifer Bolster Partner Hancock Estabrook, LLP. Friday, February 26 th Today s Objectives

More information

The 340B drug discount program was created in 1992

The 340B drug discount program was created in 1992 Proposed Rule Changes for 340B Programs: Overview and Impact Anthony Zappa, PharmD, MBA Specialty Healthcare Benefits Council The 340B drug discount program was created in 1992 as a means for certain nonprofit

More information

RE: Proposed Rule: RIN 0906-AA90, 340B Drug Pricing Program; Administrative Dispute Resolution, (Vol. 81, No. 156, August 12, 2016)

RE: Proposed Rule: RIN 0906-AA90, 340B Drug Pricing Program; Administrative Dispute Resolution, (Vol. 81, No. 156, August 12, 2016) Krista Pedley, Pharm.D, MS Captain, USPHS Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, Mail Stop 08W05A Rockville, MD 20857 RE: Proposed Rule: RIN

More information

How to Survive a HRSA Audit & Take Corrective Action. William von Oehsen, Principal Powers Pyles Sutter & Verville, PC

How to Survive a HRSA Audit & Take Corrective Action. William von Oehsen, Principal Powers Pyles Sutter & Verville, PC How to Survive a HRSA Audit & Take Corrective Action William von Oehsen, Principal Powers Pyles Sutter & Verville, PC Statement of Conflicts of Interest William von Oehsen represents 340B providers and

More information

Webinar Schedule. I. A Guide to the 340B Omnibus Guidance 340B Background Guide to the Guidance

Webinar Schedule. I. A Guide to the 340B Omnibus Guidance 340B Background Guide to the Guidance Webinar Schedule I. A Guide to the 340B Omnibus Guidance 340B Background Guide to the Guidance II. Stakeholder Response to the 340B Ceiling Price and Manufacturer CMP Proposed Rule Thursday, Oct. 8, 2005

More information

340B Drug Discount Program: Expansion Issues, Diversion Concerns, and Implications for Price Reporting and Compliance

340B Drug Discount Program: Expansion Issues, Diversion Concerns, and Implications for Price Reporting and Compliance BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. 340B Drug Discount Program: Expansion Issues,

More information

Contract Pharmacy Arrangements in the 340B Program. Conflicts of Interest. Learning Objectives 2/10/2014. OIG Memorandum Report:

Contract Pharmacy Arrangements in the 340B Program. Conflicts of Interest. Learning Objectives 2/10/2014. OIG Memorandum Report: OIG Memorandum Report: Contract Pharmacy Arrangements in the 340B Program (OEI-05-13-00431) Adam Freeman, Program Analyst U.S. Department of Health & Human Services Office of Inspector General February

More information

TX Health and Human Services Commission Proposed Rule: 340B Program Reimbursement

TX Health and Human Services Commission Proposed Rule: 340B Program Reimbursement January 31, 2014 VIA ELECTRONIC SUBMISSION Vendor Drug Program Medicaid/CHIP Division 4900 N. Lamar Austin, Texas 78751 RE: TX Health and Human Services Commission Proposed Rule: 340B Program Reimbursement

More information

340B Program: Mega Guidance, Mega Change Pershing Yoakley & Associates, PC (PYA).

340B Program: Mega Guidance, Mega Change Pershing Yoakley & Associates, PC (PYA). 340B Program: Mega Guidance, Mega Change No portion of this white paper may be used or duplicated by any person or entity for any purpose without the express written permission of PYA. For many years,

More information

NCPDP Electronic Prescribing Standards

NCPDP Electronic Prescribing Standards NCPDP Electronic Prescribing Standards May 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health care

More information

December 1, Maryland Department of Health and Mental Hygiene. Prepared by:

December 1, Maryland Department of Health and Mental Hygiene. Prepared by: Report in Response to Legislative Request to the Maryland Department of Health and Mental Hygiene to Study the Feasibility of Purchasing Prescription Drugs through Federally Qualified Health Centers and

More information

BKD NATIONAL HEALTH CARE GROUP

BKD NATIONAL HEALTH CARE GROUP BKD NATIONAL HEALTH CARE GROUP PRESCRIPTION FOR 340B SUCCESS IN 2018 February 14, 2018 BRIAN BELL DIRECTOR BBELL@BKD.COM TO RECEIVE CPE CREDIT Participate in entire webinar Answer polls when they are provided

More information

ATTN: Comments on 340B Drug Pricing Program Omnibus Guidance

ATTN: Comments on 340B Drug Pricing Program Omnibus Guidance October 27, 2015 Krista Pedley Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Rockville, MD 20857 ATTN: Comments on 340B Drug Pricing Program Omnibus

More information

340B Contract Pharmacy Arrangements: What Does the Future Hold?

340B Contract Pharmacy Arrangements: What Does the Future Hold? Presenting a live 90-minute webinar with interactive Q&A 340B Contract Pharmacy Arrangements: What Does the Future Hold? Structuring Arrangements, Meeting Legal and Regulatory Requirements THURSDAY, DECEMBER

More information

Assessing and Maximizing Your Pharmacy Program

Assessing and Maximizing Your Pharmacy Program Assessing and Maximizing Your Pharmacy Program Adirondack Park HHHN New York State 12 Sites 75+ Providers 70,000 Annual Users 250,000 Encounters 1,000,000+ Prescriptions Written HHHN s Alternative Methods

More information

CRS Report for Congress Received through the CRS Web

CRS Report for Congress Received through the CRS Web CRS Report for Congress Received through the CRS Web Order Code RS20295 August 9, 1999 Outpatient Prescription Drugs: Acquisition and Reimbursement Policies Under Selected Federal Programs Heidi G. Yacker

More information

Operations Manager: H&HS Director:

Operations Manager: H&HS Director: CHCLC Policies & Procedures Manual This Policy Covers: X All Sites All Primary Care Sites School-Based Health Centers Dental Program AD-054a Ltr Section Issue Date: 8/15/2018 Replaces: Nursing Supervisor:

More information

The Future of 340B. Disclosure

The Future of 340B. Disclosure 1 The Future of 340B NCPA 2018 Annual Convention Susan Pilch, JD, Senior Vice President, Legal and Advocacy, 340B Health Amanda Gaddy, RPh, Co Founder, Secure340B Disclosure Susan Pilch declares no conflicts

More information

The 340B Program: Challenges and Opportunities

The 340B Program: Challenges and Opportunities The 340B Program: Challenges and Opportunities March 2015 Thomas Barker Igor Gorlach Foley Hoag LLP Overview Overview and History of the 340B Program ACA s Changes to the 340B Program Recent Developments

More information

Rx Office Hours: IMPORTANT

Rx Office Hours: IMPORTANT Rx Office Hours: IMPORTANT To ensure a high quality audio experience for all, please: Dial in using your phone (NOT your computer.) Enter your personal Attendee ID (located in the left hand box, below

More information

Department of Legislative Services Maryland General Assembly 2002 Session

Department of Legislative Services Maryland General Assembly 2002 Session Department of Legislative Services Maryland General Assembly 2002 Session HB 1227 FISCAL NOTE Revised House Bill 1227 (Delegates Shriver and Hurson) Economic Matters and Environmental Matters Citizens'

More information

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Pricing & Reimbursement. Effective Date. March 2018

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Pricing & Reimbursement. Effective Date. March 2018 Texas Vendor Drug Program Pharmacy Provider Procedure Manual Pricing & Reimbursement Effective Date March 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual.

More information

December 15, 2017 (31 State SPAs)

December 15, 2017 (31 State SPAs) New State SPAs Reimburse 340B Covered Entities at Actual Acquisition Cost: Creates Disincentives For 340B Entities to Choose the Lowest Cost Drugs December 15, 2017 (31 State SPAs) On January 21, 2016,

More information

Ryan White & the Affordable Care Act: Frequently Asked Questions

Ryan White & the Affordable Care Act: Frequently Asked Questions 1 of 10 9/13/2013 4:23 PM HIV/AIDS Programs Home Ryan White & the Affordable Care Act: Frequently Asked Questions Share 0 Here you will find answers to frequently asked questions about the Ryan White Program

More information

Health Benefits Briefing

Health Benefits Briefing Health Benefits Briefing Teacher Retirement System of Texas December 7, 2016 Copyright 2015 GRS All rights reserved. TRS-Care Health Care Program For Retired Public School Employees and Their Dependents

More information

340B Compliance: Overcoming Challenges with Diversion, Duplicate Discounts, and Orphan Drug Restrictions

340B Compliance: Overcoming Challenges with Diversion, Duplicate Discounts, and Orphan Drug Restrictions Presenting a live 90-minute webinar with interactive Q&A 340B Compliance: Overcoming Challenges with Diversion, Duplicate Discounts, and Orphan Drug Restrictions WEDNESDAY, JANUARY 15, 2014 1pm Eastern

More information

Rate Component Overview

Rate Component Overview Oxford Health Plans (NY), Inc. Oxford Health Insurance, Inc. New York Small Group POS Plans Narrative Summary of Requested Rate Changes Effective 4th quarter 2013 We have prepared this Narrative Summary

More information

Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program

Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program Billing Code: 4165-15 DEPARTMENT OF HEALTH AND HUMAN SERVICES 42 CFR Part 10 RIN 0906- AA94 Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program AGENCY: Health Resources and Services

More information

OREGON HEALTH AUTHORITY

OREGON HEALTH AUTHORITY HEALTH WEALTH CAREER OREGON HEALTH AUTHORITY PROFESSIONAL DISPENSING FEE SURVEY February 2, 2017 Presenters Shawna Kittridge, Mercer Jim Cook, Mercer Ralph Magrish, Mercer Scott Banken, Mercer Deborah

More information

Compliance Risk Areas for Health Centers: A Financial Perspective. Marcie H. Zakheim Partner

Compliance Risk Areas for Health Centers: A Financial Perspective. Marcie H. Zakheim Partner Compliance Risk Areas for Health Centers: A Financial Perspective Marcie H. Zakheim Partner DISCLAIMER This training has been prepared by the attorneys of Feldesman Tucker Leifer Fidell LLP. The opinions

More information

Center for Medicaid, CHIP, and Survey & Certification SMDL# PPACA# 2. April 22, Re: Medicaid Prescription Drug Rebates

Center for Medicaid, CHIP, and Survey & Certification SMDL# PPACA# 2. April 22, Re: Medicaid Prescription Drug Rebates DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop S2-26-12 Baltimore, Maryland 21244-1850 Center for Medicaid, CHIP, and Survey & Certification

More information

Table of Contents. I. Executive Summary and Introduction..2 A. Overview.2 B. Key Findings...2 C. Summary of Approach...5

Table of Contents. I. Executive Summary and Introduction..2 A. Overview.2 B. Key Findings...2 C. Summary of Approach...5 Table of Contents I. Executive Summary and Introduction..2 A. Overview.2 B. Key Findings...2 C. Summary of Approach......5 II. III. Detailed Data Analyses Findings...6 A. Louisiana Rankings on Key Metrics....6

More information

The Rural Beneficiary Need for a Medicare Drug Benefit Delivered Through the Rural Delivery System

The Rural Beneficiary Need for a Medicare Drug Benefit Delivered Through the Rural Delivery System The Rural Beneficiary Need for a Medicare Drug Benefit Delivered Through the Rural Delivery System Keith J. Mueller, Ph.D. Director, RUPRI* Center for Rural Health Policy Analysis and Chair, RUPRI Rural

More information

The AIDS Drug Assistance Program Overview

The AIDS Drug Assistance Program Overview The AIDS Drug Assistance Program Overview Ryan White HIV/AIDS Part B Program Administrative Reverse Site Visit Meeting November 6, 2014 Glenn Clark, MSW U.S. Department of Health and Human Services (HHS)

More information

Rx Watchdog Report Comparative Measures of Price Change for Prescription Drugs and Other Goods

Rx Watchdog Report Comparative Measures of Price Change for Prescription Drugs and Other Goods Rx Watchdog Report Comparative Measures of Price Change for Prescription Drugs and Other Goods Stephen W. Schondelmeyer PRIME Institute, University of Minnesota Leigh Purvis AARP Public Policy Institute

More information

Appendix I: Data Sources and Analyses. Appendix II: Pharmacy Benefit Management Tools

Appendix I: Data Sources and Analyses. Appendix II: Pharmacy Benefit Management Tools Appendix I: Data Sources and Analyses This brief includes findings from analyses of the Centers for Medicare & Medicaid Services (CMS) State Drug Utilization Data 1 and CMS 64 reports for federal fiscal

More information

Best Practices for 340B Internal Audits and Key Takeaways from the Winter 340B Coalition Conference

Best Practices for 340B Internal Audits and Key Takeaways from the Winter 340B Coalition Conference Best Practices for 340B Internal Audits and Key Takeaways from the Winter 340B Coalition Conference February 9, 2017 1 Webinar Panelists! The Panel! Tammy Zukowski, MBA! Douglas E. Miller, Pharm.D.! William

More information

The Florida Legislature

The Florida Legislature The Florida Legislature OFFICE OF PROGRAM POLICY ANALYSIS AND GOVERNMENT ACCOUNTABILITY RESEARCH MEMORANDUM Feasibility of Consolidating Statewide Pharmaceutical Services Summary As directed by Ch. 2009-15,

More information

Understanding Pharmacy Benefit Management Services

Understanding Pharmacy Benefit Management Services Understanding Pharmacy Benefit Management Services Peter Cullen VP, Business Development and Strategic Initiatives March 12, 2014 Innovation Session Overview and Learning Objectives Session Overview: Provide

More information

RE: 340B Civil Monetary Penalties for Manufacturers and Ceiling Price Regulations (RIN AA89)

RE: 340B Civil Monetary Penalties for Manufacturers and Ceiling Price Regulations (RIN AA89) Office of Pharmacy Affairs Healthcare Systems Bureau Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, MD 20857 Submitted via www.regulations.gov RE: 340B Civil

More information

Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011

Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011 Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011 Keeping your money in your pocket, where it belongs. Risk

More information

Aaron Vandervelde Managing Director Berkeley Research Group

Aaron Vandervelde Managing Director Berkeley Research Group Aaron Vandervelde Managing Director Berkeley Research Group Statement re Interests Aaron Vandervelde provides services as an independent consultant concerning 340B matters to pharmaceutical manufacturers

More information

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.

LEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty. 0-0 LEGISLATURE LRB-/ 0 AN ACT to create.0 of the statutes; relating to: prescription drug cost reporting by manufacturers and providing a penalty. Analysis by the Legislative Reference Bureau This bill

More information

Summary Plan Description Accenture Prescription Drug Plan

Summary Plan Description Accenture Prescription Drug Plan Summary Plan Description Accenture Prescription Drug Plan Effective January 1, 2018 Group Number: ACCRXS1 TABLE OF CONTENTS SECTION 1 - WELCOME... 1 SECTION 2 PLAN HIGHLIGHTS... 3 SECTION 3 - ADDITIONAL

More information

Assuring Medicaid Patients Access to Pharmacy Services Through Adequate Dispensing Fees

Assuring Medicaid Patients Access to Pharmacy Services Through Adequate Dispensing Fees January 25, 2012 Ms. Cindy Mann, Deputy Administrator and Director Center for Medicaid, CHIP and Survey & Certification Centers for Medicare & Medicaid Services Department of Health and Human Services

More information

Aetna. CCHCA Physician Handbook (7 th Edition)

Aetna. CCHCA Physician Handbook (7 th Edition) Part II Section A Aetna Introduction 1 Verifying Aetna Member Eligibility and Benefits 1 Aetna Sample Member ID Card 2 Aetna Prescription Drug Program 3 Pharmacy Benefit 4 Prior Authorization for Medications

More information

August 11, Submitted electronically via Regulations.gov

August 11, Submitted electronically via Regulations.gov August 11, 2017 Submitted electronically via Regulations.gov Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1678-P PO Box 8013 Baltimore, MD 21244-1850

More information

Federal Spending on Brand Pharmaceuticals. April 2011

Federal Spending on Brand Pharmaceuticals. April 2011 Federal Spending on Brand Pharmaceuticals April 2011 Summary Avalere Health estimates that manufacturers of brand-name prescription drugs will receive about $777 billion in revenues from the sales of outpatient

More information

Page 1 of 21 Page 1 Purpose of This Survey The Ohio Department of Medicaid (ODM) has engaged Mercer Government Human Services Consulting (Mercer), part of Mercer Health & Benefits LLC, to conduct a survey

More information

PRESCRIPTION DRUG EXPENSE BENEFIT 2019

PRESCRIPTION DRUG EXPENSE BENEFIT 2019 PRESCRIPTION DRUG EXPENSE BENEFIT 2019 Welcome to the Prescription Drug benefit, administered by Express Scripts, Inc. (ESI). To receive the highest level of benefits, prescription drugs must be obtained

More information

Get a 1-month supply of ENTRESTO at no cost to you*

Get a 1-month supply of ENTRESTO at no cost to you* Get a 1-month supply of ENTRESTO at no cost to you* FREE TRIAL OFFER * For all patients A program designed to guide you through treatment *Limitations apply. This voucher is good for a 30-day (maximum

More information

Blue care network pre authorization. Blue care network pre authorization

Blue care network pre authorization. Blue care network pre authorization Paieška Paieška Paieška Blue care network pre authorization Blue care network pre authorization > > Blue Cross Complete (Medicaid) BCN Advantage HMO-POS Formulary Custom Formulary Prior Authorization and

More information

State Employees' Group Health Self-Insurance Trust Fund

State Employees' Group Health Self-Insurance Trust Fund State Employees' Group Health Self-Insurance Trust Fund Report on the Financial Outlook For the Fiscal Years Ending June 30, 2012 through June 30, 2016 Presented January 4, 2012 Prepared by: Florida Department

More information

Medicare 340B Drug Changes Effective 1/1/18. Paul Hernandez, Sr. Manager, Business Health nthrive, Inc.

Medicare 340B Drug Changes Effective 1/1/18. Paul Hernandez, Sr. Manager, Business Health nthrive, Inc. Medicare 340B Drug Changes Effective 1/1/18 Paul Hernandez, Sr. Manager, Business Health nthrive, Inc. 2016 nthrive, Inc. All rights reserved. RV06212016 Statement of Conflicts of Interest PAUL HERNANDEZ

More information

AccessCUBICIN Enrollment Form

AccessCUBICIN Enrollment Form Services Requested REQUIRED Choose the Services that are being Requested INSTRUCTIONS FOR COMPLETING THIS FORM Patient Information REQUIRED Include the primary contact; if other than the patient, include

More information

Big Springs Medical Association, Inc. d/b/a Missouri Highlands Health Care. Independent Auditor s Report and Financial Statements

Big Springs Medical Association, Inc. d/b/a Missouri Highlands Health Care. Independent Auditor s Report and Financial Statements Independent Auditor s Report and Financial Statements Independent Auditor s Report Board of Directors Ellington, Missouri We have audited the accompanying financial statements of, d/b/a Missouri Highlands

More information

Florida Medicaid. Prescribed Drugs Services Coverage Policy. Agency for Health Care Administration. Draft Rule

Florida Medicaid. Prescribed Drugs Services Coverage Policy. Agency for Health Care Administration. Draft Rule Florida Medicaid Prescribed Drugs Services Coverage Policy Agency for Health Care Administration Draft Rule Table of Contents Introduction... 1 1.1 Description... 1 1.2 Legal Authority... 1 1.3 Definitions...

More information

THE OHIO DEPARTMENT OF MEDICAID

THE OHIO DEPARTMENT OF MEDICAID HEALTH WEALTH CAREER THE OHIO DEPARTMENT OF MEDICAID PHARMACY STAKEHOLDER ENGAGEMENT MEETING September 13, 2016 Presenter Scott Banken, Mercer WHY WHO HOW The ODM is conducting a Professional Dispensing

More information